<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Clontech Laboratories, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 77-0035190
- --------------------------------------------------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification No.)
1020 East Meadow Circle, Palo Alto, CA 94303
- --------------------------------------------------------------------------------
(Address of principal executive office) (Zip code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box: / /
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box: /X/
Securities Act registration statement number to which this form relates:
333-72607
(if applicable)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Common Stock to be registered hereunder is contained
in the section entitled "Description of Capital Stock," commencing at page 50 of
the Prospectus included in the Registrant's Form S-1 Registration Statement, as
amended (No. 333-72607), initially filed with the Securities and Exchange
Commission on February 19, 1999 and is incorporated herein by reference.
ITEM 2. EXHIBITS.
EXHIBIT
NUMBER DESCRIPTION
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized.
CLONTECH LABORATORIES, INC.
Date: February 25, 1999 By: /s/ Kenneth S. Fong
-------------------------------------
Kenneth S. Fong
President and Chief Executive Officer
